Cargando…
Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
Potency testing and release of annual influenza vaccines require preparation, calibration, and distribution of reference antigens (RAs) and antisera every year, which takes an average of 8 to 12 weeks, and can be a major limiting factor in pandemic situations. Here we describe for the first time a r...
Autores principales: | Narayan, Kartik, Paduraru, Crina, Blake, Taylor, Arunachalam, Arun B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344355/ https://www.ncbi.nlm.nih.gov/pubmed/37457687 http://dx.doi.org/10.3389/fimmu.2023.1128683 |
Ejemplares similares
-
Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017) -
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2018) -
Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022) -
A direct contact pig influenza challenge model for assessing protective efficacy of monoclonal antibodies
por: McNee, Adam, et al.
Publicado: (2023) -
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
por: Vigil, Adam, et al.
Publicado: (2018)